Cardiac cachexia is a complex and severe condition characterized by the unintended loss of weight, muscle atrophy, and weakness in individuals with chronic heart failure. This condition goes beyond mere weight loss, encompassing a profound depletion of lean body mass and fat stores. It poses a significant challenge in the management of heart failure, often leading to increased morbidity and mortality. The underlying mechanisms of cardiac cachexia involve a complex interplay of inflammation, hormonal imbalance, and metabolic disturbances. Clinically, patients with cardiac cachexia experience a decline in functional capacity and a compromised quality of life. Management strategies typically involve a multidisciplinary approach, focusing on nutritional support, exercise rehabilitation, and addressing the underlying causes of heart failure. Research into the pathophysiology and treatment options for cardiac cachexia is ongoing, aiming to enhance our understanding and improve the prognosis for individuals affected by this debilitating condition.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain